Christopher M. Capozzi, the Chief Financial Officer of $LIFE, sold 15,197 shares of the company on 08-17-2026 for an estimated $515,482. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.3% of their shares of this class of stock. Following this trade, they now own 650,031 shares of this class of $LIFE stock.
$LIFE Insider Trading Activity
$LIFE insiders have traded $LIFE stock on the open market 33 times in the past 6 months. Of those trades, 0 have been purchases and 33 have been sales.
Here’s a breakdown of recent trading of $LIFE stock by insiders over the last 6 months:
- 2019 GP, L.L.C. GV has made 0 purchases and 15 sales selling 754,824 shares for an estimated $15,125,689.
- BRANDT WALTER KUCHARSKI (Chief Accounting Officer) has made 0 purchases and 6 sales selling 88,870 shares for an estimated $3,025,226.
- CHRISTOPHER M. CAPOZZI (Chief Financial Officer) has made 0 purchases and 4 sales selling 106,770 shares for an estimated $2,677,572.
- PETER GEORGE COLIS (CEO and Secretary) has made 0 purchases and 4 sales selling 89,377 shares for an estimated $2,327,796.
- LINGKE WANG (President) has made 0 purchases and 4 sales selling 68,972 shares for an estimated $1,800,186.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$LIFE Hedge Fund Activity
We have seen 37 institutional investors add shares of $LIFE stock to their portfolio, and 37 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DIVISADERO STREET CAPITAL MANAGEMENT, LP added 1,635,921 shares (+inf%) to their portfolio in Q2 2026, for an estimated $29,675,606
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 1,582,556 shares (+inf%) to their portfolio in Q2 2026, for an estimated $28,707,565
- CITADEL ADVISORS LLC removed 390,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $7,074,600
- SCHONFELD STRATEGIC ADVISORS LLC removed 355,261 shares (-88.7%) from their portfolio in Q2 2026, for an estimated $6,444,434
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND removed 350,000 shares (-50.0%) from their portfolio in Q2 2026, for an estimated $6,349,000
- GOLDMAN SACHS GROUP INC removed 300,039 shares (-60.9%) from their portfolio in Q2 2026, for an estimated $5,442,707
- GLADE BROOK CAPITAL PARTNERS LLC removed 285,952 shares (-25.0%) from their portfolio in Q2 2026, for an estimated $5,187,169
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$LIFE Analyst Ratings
Wall Street analysts have issued reports on $LIFE in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citizens issued a "Market Outperform" rating on 02/23/2026
- Goldman Sachs issued a "Buy" rating on 02/23/2026
- Baird issued a "Outperform" rating on 02/23/2026
- B of A Securities issued a "Buy" rating on 02/23/2026
- William Blair issued a "Outperform" rating on 02/23/2026
To track analyst ratings and price targets for $LIFE, check out Quiver Quantitative's $LIFE forecast page.
$LIFE Price Targets
Multiple analysts have issued price targets for $LIFE recently. We have seen 9 analysts offer price targets for $LIFE in the last 6 months, with a median target of $21.0.
Here are some recent targets:
- Ross Sandler from Barclays set a target price of $27.0 on 05/08/2026
- Matthew J. Carletti from Citizens set a target price of $27.0 on 05/07/2026
- Ronald Josey from Citigroup set a target price of $16.0 on 02/26/2026
- Lee Horowitz from Deutsche Bank set a target price of $23.0 on 02/24/2026
- Eric Sheridan from Goldman Sachs set a target price of $33.0 on 02/23/2026
- Colin Sebastian from Baird set a target price of $18.0 on 02/23/2026
- Michael McGovern from B of A Securities set a target price of $15.0 on 02/23/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
